Global Atherectomy Device Market By Overview
Introduction:
A minimal invasive surgery to increase the lumen diameter by removing plaque blockages from coronary and peripheral vessels is called as atherectomy. There is a minimum damage to the surrounding vessels and arteries in this process. This procedure involves an ablation technique in the form of directional excision, as well as rotational, orbital and laser ablation. These devices were developed to permit drilling, grinding, or sanding of atheroma, calcium, and excess cellular material from the site of coronary occlusion or stenosis. Both mechanical and laser-based approaches are used. It is a minimally invasive procedure similar to angioplasty. It is performed to cut away plaque that has built up in the arteries. After the plaque is removed, a stent may be placed to keep the artery open. Laser atherectomy is a minimally invasive procedure designed to allow the damaged blood vessel to dilate, increasing blood flow and providing for the necessary oxygenation of the tissues involved. This procedure is particularly helpful in treating arterial blockages in smaller branches of blood vessels. The global atherectomy device market accounted for US$ 541.65 million in 2020 and is estimated to be US$ 1207.81 million by 2030 and is anticipated to register a CAGR of 8.4%.
Global Atherectomy Device Market By Dynamics
Rising initiatives by government bodies
The global atherectomy device market is growing due to the rise in the cardiovascular diseases which is the major driving factor for the growth of the target market. The continuous rise in the artery blockage in the geriatric population and the cardiovascular diseases give rise to number of atherectomy procedures hence increasing the target market. As the atherectomy procedure is easy, less infectious and has a minimal surgery procedure and complications, it is more preferred over the surgical procedures. Furthermore, the favorable healing period after the atherectomy enhances the global atherectomy device market. In addition, the incidence of the chronic diseases increases the market for atherectomy devices.
The availability of substitute devices in a lower cost like balloon angioplasty will hamper the global atherectomy device market. Further advancements in atherectomy device have rationalized the concept of minimal invasive interventions. Moreover, ultra-precision in performing cuts and ablations through the utilization of diamond-coated crowns and ablating heads leads to minimal vascular injuries which is a major trend in the global atherectomy device market
Global Atherectomy Device Market By Segmentation
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
The global atherectomy device market is segmented based on device type, disease site, application end user and region.
Based on device type, the global atherectomy device market is classified into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and laser atherectomy devices. On the basis of diseases site, the target market is categorized as coronary artery disease and peripheral artery disease. On the basis of application, the target market is segmented as cardiovascular atherectomy devices, neurovascular devices and peripheral vascular atherectomy devices. On the basis of end user global atherectomy device market is divide into hospitals, clinics and ambulatory surgical centers.
Regional Insights:
The global atherectomy device market accounted for US$ 541.65 billion in 2020 and is estimated to be US$ 1207.81 billion by 2030 and is anticipated to register a CAGR of 8.4%. On region the global atherectomy device market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has the largest share in the global atherectomy device market followed by other regions. This can be attributed to high prevalence of the peripheral and coronary artery diseases combined with the large number of patients with life-style related complications are the primary factors leading to the dominance of North American market. Further, availability of the advanced technologies for the treatment of these diseases are the other factors contributing to the supremacy of the target market in this region. Moreover, the European market second largest market overall the globe as it has a high preference for minimal invasive surgical processes which thrives the global atherectomy device market.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Device Type- Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, and Laser Atherectomy Devices By Disease Site- Coronary Artery Disease and Peripheral Artery Disease By Application– Cardiovascular Atherectomy Devices, Neurovascular Devices, and Peripheral Vascular Atherectomy Devices By End User- Hospitals, Clinics, and Ambulatory Surgical Centers |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global atherectomy device market report based on device type, disease site, application, end user and region.
Global Atherectomy device Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
-
- North America
-
Rest of Middle East & Africa
Global Atherectomy Device Market By Key Players
The key players operating in the global atherectomy device market includes Bayer HealthCare, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Cardiovascular Systems, Inc., Spectranetics, Philips Holding USA, Inc., Straub Medical AG, Abbott Laboratories and Terumo Interventional Systems. Technological advancements in the product and product launches are some trends which are witnessed in the global atherectomy device market.
Bayer Healthcare, Inc:
Bayer launches two new Jetstream XC and SC Atherectomy catheters features both front cutting tip and expandable blade technology for use in larger vessels
Global Atherectomy Device Market By Key Issues Addressed
Key Issues Addressed
- What is the scope of the market research report?
The global atherectomy device market is segmented based on device type, disease type, application, end-user, and region.
- What are the growing factors related with the market global atherectomy devices growth?
Rising cardiovascular diseases is the major factor driving growth of the global market
- What are the regions considered in the report & which region will dominate the market?
North America has the largest share in the global atherectomy device market followed by other regions.
- What are the leading players in the global atherectomy devices market?
Some of the prominent players operating in the global atherectomy device market include Bayer HealthCare, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Cardiovascular Systems, Inc., Spectranetics, Philips Holding USA, Inc., Straub Medical AG, Abbott Laboratories and Terumo Interventional Systems
Global Atherectomy Device Market By Company Profile
Company Profile:
- Bayer HealthCare, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- R. Bard, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cardinal Health
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cardiovascular Systems, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Spectranetics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Philips Holding USA, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Straub Medical AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Terumo Interventional Systems
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
Business Strategies
Global Atherectomy Device Market By Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- PORTER’s
- Investment Outlook
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Atherectomy Device Strategies
- Key Questions this Study will Answer
-
- By Device Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, and Laser Atherectomy Devices),
- By Diseases Site (Coronary Artery Disease and Peripheral Artery Disease),
- By Application (Cardiovascular Atherectomy Devices, Neurovascular Devices and Peripheral Vascular Atherectomy Devices),
- By End User (Hospitals, Clinics and Ambulatory Surgical Centers),
- By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Regional Analysis
- Regional Revenue Analysis
- Regional By segment Analysis
- Reasons for regional growth
- Key Player of particular region
- Countries Include in the report:
-
-
- North America (U.S., Canada)
- Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
- Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)
-
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Competitive Overview
- Competitive Benchmarking
- Market Share Analysis
- Key Developments In The Global Atherectomy Device Market
- Key Developments: Mergers & Acquisitions
- Key Developments: Collaboration
- Key Developments: Contracts & Agreements
- Key Developments: Expansion
- Key Developments: Product Developments
- Company Profiles
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- SWOT Analysis
-
- Bayer HealthCare, Inc.
- Boston Scientific Corporation
- R. Bard, Inc.
- Cardinal Health
- Cardiovascular Systems, Inc.
- Spectranetics
- Philips Holding USA, Inc.
- Straub Medical AG
- Abbott Laboratories
- Terumo Interventional Systems.
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The atherectomy device market is segmented based on device type, disease site, application end user and region.
High Costs, Limited Awareness, Regulatory Challenges, Competition from Alternative Treatments.
Increasing Cardiovascular Diseases, Technological Advancements, Aging Population, Minimally Invasive Procedures.
By region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating in the global atherectomy device market includes Bayer HealthCare, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Cardiovascular Systems, Inc., Spectranetics, Philips Holding USA, Inc., Straub Medical AG, Abbott Laboratories and Terumo Interventional Systems.